Onkologie. 2019:13(1):14-18 | DOI: 10.36290/xon.2019.003

Breast cancer and pregnancy

Zuzana Bielčiková
Onkologická klinika VFN a 1. LF UK v Praze

Breast cancer (BC) and pregnancy can be viewed from several perspectives (see points below). Current knowledge and recommendations by their complexity include all of them and can be summarized as follows: 1. Pregnancy planning in women after treatment for BC: „„there is no doubt about the safety of pregnancy in women after treatment of BC, „„the optimum gap between treatment of BC and pregnancy is the subject of ongoing studies. 2. Fertility preservation in BC patients: „„optimal strategy includes oocyte/embryo cryopreservation in the period prior to chemotherapy and LHRH analogue administration during its course. 3. Management of gestational BC treatment: „„gestational BC therapy should mimic as much as possible the treatment of non-pregnant women, „„chemotherapy can be applied in the 2nd and 3rd trimester of pregnancy, breast surgery and sentinel node scintigraphy is generally possible at any time during pregnancy, endocrine therapy, targeted anti-HER2 therapy must be postponed for the postpartum period, „„induction of abortion has no effect on the prognosis of mother.

Keywords: breast cancer, pregnancy, fertility preservation, gestational breast cancer, breast cancer in young women, chemotherapy-induced infertility

Published: March 15, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bielčiková Z. Breast cancer and pregnancy. Onkologie. 2019;13(1):14-18. doi: 10.36290/xon.2019.003.
Download citation

References

  1. Brinton LA, Sherman ME, Carreon JD, et al. Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst. 2008; 100: 1643-1648. Go to original source... Go to PubMed...
  2. Stensheim H, Cvancarova M, M?ller B, et al. Pregnancy after adolescent and adult cancer: a population-based matched cohort study. Int J Cancer 2011; 129(5): 1225-1236. Go to original source... Go to PubMed...
  3. Anderson RA, Brewster DH, Wood R, et al. The impact of cancer on subsequent chance of pregnancy: a population-based analysis. Human Reproduction 2018; 33(7): 1281-1290. Go to original source... Go to PubMed...
  4. Letourneau JM, Smith JF, Ebbel EE, et al. Racial, socioeconomic, and demographic disparities in access to fertility preservation in young women diagnosed with cancer. Cancer 2012; 118(18): 4579-4588. Go to original source... Go to PubMed...
  5. Azim HA, Santoro L, Pavlidis N, et al. Safety of pregnancy following breast cancer diagnosis: A meta-analysis of 14 studies. Eur J of Cancer 2011; 47(1): 74-83. Go to original source... Go to PubMed...
  6. Valachis A, Tsali L, Pesce LL, et al. Safety of pregnancy after primary breast carcinoma in young women: a meta-analysis to overcome bias of healthy mother effect studies. Obstet Gynecol Surv. 2010; 65(12): 786-693. Go to original source... Go to PubMed...
  7. Lambertini M, Kroman N, Ameye L, et al. Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status. J Natl Cancer Inst. 2018; 110(4): 426-429. Go to original source... Go to PubMed...
  8. Kranick JA, Schaefer C, Rowell S, et al. Is pregnancy after breast cancer safe? Breast J. 2010; 16: 404-411. Go to original source... Go to PubMed...
  9. Gelber S, Coates AS, Goldhirsch A, et al. Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer. J Clin Oncol 2001; 19: 1671-1675. Go to original source... Go to PubMed...
  10. Azim HA, Kroman N, Paesmans M, et al. Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study. J Clin Oncol 2013; 31(1): 73-79. Go to original source... Go to PubMed...
  11. Song RX, Mor G, Naftolin F, et al. Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17beta-estradiol. J Natl Cancer Inst 2001;93:1714-1723. Go to original source... Go to PubMed...
  12. Kamper-J?rgensen M, Biggar RJ, Tj?nneland A, et al. Opposite effects of microchimerism on breast and colon cancer. Eur J Cancer 2012; 48: 2227-2235. Go to original source... Go to PubMed...
  13. Ives A, Saunders C, Bulsara M, et al. Pregnancy after breast cancer: Population based study. BMJ 2007; 334: 194. Go to original source... Go to PubMed...
  14. Iqbal J, Amir E, Rochon PA, et al. Association of the Timing of Pregnancy With Survival in Women With Breast Cancer. JAMA Oncol. 2017; 3(5): 659. Go to original source... Go to PubMed...
  15. Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer (POSITIVE). ClinicalTrials.gov Identifier: NCT02308085.
  16. Stearns V, Schneider B, Henry NL, et al. Breast cancer treatment and ovarian failure: risk factors and emerging genetic determinants. Nature Rev Cancer 2006; 6(11): 886-893. Go to original source... Go to PubMed...
  17. Peccatori FA, Azim HA, Orecchia R, et al. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2013; 24(suppl 6): vi160-vi170. Go to original source... Go to PubMed...
  18. Oktay K, Harvey BE, Partridge AH, et al. Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update. JCO 2018; 36(19): 1994-2001. Go to original source... Go to PubMed...
  19. Paluch-Shimon S, Pagani O, Partridge AH, et al. ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3). The Breast 2017; 35: 203-217. Go to original source... Go to PubMed...
  20. Lambertini M, Cinquini M, Moschetti I, et al. Temporary ovarian suppression during chemotherapy to preserve ovarian function and fertility in breast cancer patients: A GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology. Eur J Cancer 2017; 71: 25-33. Go to original source... Go to PubMed...
  21. Lambertini M, Di Maio M, Pagani O, et al. The BCY3/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients. The Breast 2018; 42: 41-49. Go to original source... Go to PubMed...
  22. Azim HA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol. 2008; 26(16): 2630-2635. Go to original source... Go to PubMed...
  23. Kim J, Turan V, Oktay K. Long-Term Safety of Letrozole and Gonadotropin Stimulation for Fertility Preservation in Women With Breast Cancer. JCEM 2016; 101(4): 1364-1371. Go to original source... Go to PubMed...
  24. Lambertini M, Ceppi M, Poggio F, et al. Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies. Ann of Oncol 2015; 26(12): 2408-2419. Go to original source... Go to PubMed...
  25. Navrozoglou I, Vrekoussis T, Kontostolis E, et al. Breast cancer during pregnancy: a mini-review. Eur J Surg Oncol. 2008; 34(8): 837-843. Go to original source... Go to PubMed...
  26. Stensheim H, M?ller B, van Dijk T, Foss? SD. Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol 2009; 27: 45-51. Go to original source... Go to PubMed...
  27. Azim HA, Botteri E, Renne G, et al; The biological features and prognosis of breast cancer diagnosed during pregnancy: a case-control study. Acta Oncol 2012; 51(5): 653-661. Go to original source... Go to PubMed...
  28. Azim HA, Santoro L, Russell-Edu W, et al. Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies, Cancer Treat Rev 2012; 38: 834-842. Go to original source... Go to PubMed...
  29. Ray JG, Vermeulen MJ, Bharatha A, et al. Association Between MRI Exposure During Pregnancy and Fetal and Childhood Outcomes. JAMA. 2016 6; 316(9): 952-961. Go to original source... Go to PubMed...
  30. Kuczkowski KM. Nonobstetric surgery during pregnancy: what are the risks of anesthesia? Obstet Gynecol Surv 2004; 59(1): 52-56. Go to original source... Go to PubMed...
  31. Gentilini O, Masullo M, Rotmensz N, et al. Breast cancer diagnosed during pregnancy and lactation: biological features and treatment options. EJSO 2005; 31(3): 232-236. Go to original source... Go to PubMed...
  32. Duncan PG, Pope WD, Cohen MM, et al. Fetal risk of anesthesia and surgery during pregnancy. Anesthesiology 1986; 64(6): 790-794. Go to original source... Go to PubMed...
  33. Haan J, Verheecke M, Van Calsteren K, et al. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. Lancet Oncol 2018; 19: 337-334. Go to original source... Go to PubMed...
  34. Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol 2004; 5(5): 283-291. Go to original source... Go to PubMed...
  35. Ring AE, Smith IE, Jones A, et al. Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals. J Clin Oncol 2005; 23(18): 4192-4197. Go to original source... Go to PubMed...
  36. Van CalsterenK, Heyns L, De Smet F, et al. Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes, J Clin Oncol, 2010; 28: 683-689. Go to original source... Go to PubMed...
  37. Hahn KM, Johnson PH, Gordon N, et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 2006; 107(6): 1219-1226. Go to original source... Go to PubMed...
  38. Peccatori FA, Azim HA. Pregnancy in breast cancer survivors: a need for proper counseling. Breast 2009; 18(6): 337-338. Go to original source... Go to PubMed...
  39. Loibl S, Han SN, von Minckwitz G, et al. Treatment of breast cancer during pregnancy: an observational study. Lancet Oncol 2012; 13(9): 887-896. Go to original source... Go to PubMed...
  40. Mir O, Berveiller P, Goffinet F, et al. Taxanes for breast cancer during pregnancy: a systematic review. Ann of Oncol 2010; 21(2): 425-426. Go to original source... Go to PubMed...
  41. Cardonick E, Bhat A, Gilmandyar D, et al. Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature. Ann on Oncol 2012; 23(12): 3016-3023. Go to original source... Go to PubMed...
  42. Amant F, Vandenbroucke T, Verheecke M, et al. Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy. N Engl J Med 2015; 373: 1824-1834. Go to original source... Go to PubMed...
  43. Peccatori FA, Corrado G, Fumagalli M. After gestational chemotherapy, the kids are all right. Nature Rev Clin Oncol 2015; 12: 254-255. Go to original source... Go to PubMed...
  44. Kal HB, Struikmans H. Radiotherapy during pregnancy: fact and fiction. Lancet Oncol 2005; 6: 328-333. Go to original source... Go to PubMed...
  45. Spanheimer PM, Graham MM, Sugg SL, et al. Measurement of uterine radiation exposure from lymphoscintigraphy indicates safety of sentinel lymph node biopsy during pregnancy. Ann Surg Oncol 2009; 16: 1143-1147. Go to original source... Go to PubMed...
  46. Balaya V, Bonsang-Kitzis H, Ngo C, et al. What about sentinel lymph node biopsy for early breast cancer during pregnancy? J Gynecol Obstet Hum Reprod 2018; 47(5): 205-207. Go to original source... Go to PubMed...
  47. Han SN, Amant F, Cardonick EH, et al. Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy. International Network on Cancer, Infertility and Pregnancy. Breast Cancer Res Treat. 2018; 168(2): 551-557. Sentinel lymph node biopsy in pregnant women with breast cancer. Go to original source... Go to PubMed...
  48. Gropper AB, Calvillo KZ, Dominici L, et al. Sentinel lymph node biopsy in pregnant women with breast cancer. Ann Surg Oncol. 2014; 21(8): 2506-2511. Go to original source... Go to PubMed...
  49. Cardonick E, Dougherty R, Grana G, et al. Breast cancer during pregnancy: maternal and fetal outcomes. Cancer J 2010; 16(1): 76-82. Go to original source... Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.